SEC Form 4 · accession 0001140361-26-029632
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chad Thomas Campbell
Officer — SVP/GM, Vascular Access
Period of report
Jul 22, 2026
Accepted (ET)
Jul 24, 2026 · 6:10 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 22, 2026 | M | 6,466 | $0.00 | A | 111,006 | D | |
| Common StockF2 | Jul 22, 2026 | F | 2,330 | $13.82 | D | 108,676 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance RightF3 | — | Jul 22, 2026 | M | 22,768 | D | — | — | Common Stock | 22,768 | 0 | D |
Explanation of responses
- F1This acquisition of 6,466 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023.
- F2The exempt disposition of 2,330 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023.
- F3On July 19, 2023, the reporting person received a target grant of 22,768 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 6,466 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited.